| Business Summary | | Pharmaceutical
Resources,
Inc.
(PRI)
is
a
holding
company
that,
through
its
subsidiaries,
develops,
manufactures
and
distributes
a
line
of
generic
drugs
in
the
United
States.
PRI
operates
primarily
through
its
wholly
owned
subsidiary,
Par
Pharmaceutical
Inc.
(Par),
a
manufacturer
and
distributor
of
generic
drugs.
The
Company's
product
line
consists
of
both
prescription
and
over-the-counter
generic
drugs.
Par
markets
approximately
58
products,
representing
various
dosage
strengths
for
22
drugs
that
are
manufactured
by
PRI,
and
approximately
45
additional
products,
representing
various
dosage
strengths
for
23
drugs
that
are
manufactured
for
it
by
other
companies.
Products
are
marketed
principally
in
solid
oral
dosage
form,
consisting
of
tablets,
caplets
and
two-piece
hard-shell
capsules.
The
Company
also
distributes
one
product
in
the
semi-solid
form
of
a
cream. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Pharmaceutical
Resources,
Inc.
is
a
holding
company
which,
through
its
subsidiary
Par
Pharmaceutical,
Inc.,
manufactures
and
distributes
a
broad
line
of
generic
drugs.
For
the
six
months
ended
6/30/01,
net
sales
increased
35%
to
$55
million.
Net
income
totaled
$4.1
million
vs.
a
loss
of
$1.8
million.
Revenues
benefitted
from
the
introduction
of
new
products.
Net
income
also
reflects
an
increased
gross
margin
due
to
more
variable
overhead
variances. | More
from
Market Guide: Significant
Developments |
| | | | FY1999
Compensation | | Pay | Exer | |
| Kenneth Sawyer, 54 Chairman,
Pres and CEO | $482K | -- | Scott Tarriff, 40 Exec.
VP of Sales and Marketing | 239K | -- | Dennis O' Connor, 48 VP,
CFO, Sec. | 145K | $39K | Dollar amounts are as of 30-Sep-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|